{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:13:48Z","timestamp":1760346828153,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jdermsci.2019.12.007","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T11:42:10Z","timestamp":1576237330000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["CD22 and CD72 contribute to the development of scleroderma in a murine model"],"prefix":"10.1016","volume":"97","author":[{"given":"Chunyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinh Thi","family":"Ha Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Tennichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2019.12.007_bib0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0010","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity in mice and humans","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","article-title":"B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis","volume":"169","author":"Hasegawa","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0025","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1016\/S0021-9258(18)53139-2","article-title":"CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin","volume":"268","author":"Sgroi","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.176.2.873","article-title":"B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation","volume":"176","author":"Fujimoto","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1074-7613(00)80270-8","article-title":"CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice","volume":"5","author":"Sato","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/379346a0","article-title":"Augmented humoral and anaphylactic responses in FcgRII-deficient mice","volume":"379","author":"Takai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1084\/jem.189.1.179","article-title":"Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors","volume":"189","author":"Clynes","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jdermsci.2019.06.005","article-title":"CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model","volume":"95","author":"Nguyen","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0055","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","article-title":"The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice","volume":"7","author":"Hamaguchi","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.179.4.1127","article-title":"Turnover of naive- and memory-phenotype T cells","volume":"179","author":"Tough","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0065","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0070","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/art.27428","article-title":"Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator\/inducible costimulator ligand pathway","volume":"62","author":"Tanaka","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0075","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/33.8.2410480","article-title":"A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections","volume":"33","author":"Lopez-De Leon","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0090","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajpath.2016.12.016","article-title":"Blockade of p38 mitogen-activated protein kinase inhibits murine sclerodermatous chronic graft-versus-Host disease","volume":"187","author":"Matsushita","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0095","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.4049\/jimmunol.178.7.4136","article-title":"Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice","volume":"178","author":"Couper","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1074-7613(00)80124-7","article-title":"CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation","volume":"11","author":"Pan","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0105","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1002\/art.23812","article-title":"Modulation of peripheral B cell tolerance by CD72 in a murine model","volume":"58","author":"Li","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.164.3.1223","article-title":"CD72 negatively regulates signaling through the antigen receptor of B cells","volume":"164","author":"Adachi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0002-9440(10)64439-2","article-title":"Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis","volume":"161","author":"Hamaguchi","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0125","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0130","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K","article-title":"Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model","volume":"181","author":"Mori","year":"1999","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0145","first-page":"755","article-title":"Hypothesis: pathogenesis of systemic sclerosis","volume":"30","author":"Takehara","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.13156","article-title":"Biomarkers in systemic sclerosis: their potential to predict clinical courses","volume":"43","author":"Hasegawa","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0155","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2018","article-title":"Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren\u2019s syndrome: an open-label phase I\/II study","volume":"8","author":"Steinfeld","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0160","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/art.40425","article-title":"Efficacy of epratuzumab, an Anti-CD22 monoclonal IgG antibody, in systemic lupus erythematosus patients with associated Sjogren\u2019s syndrome: post hoc analyses from the EMBODY trials","volume":"70","author":"Gottenberg","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2019.12.007_bib0165","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/art.39856","article-title":"Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double-blind, placebo-controlled trials","volume":"69","author":"Clowse","year":"2017","journal-title":"Arthritis Rheumatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119303925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181119303925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:49:57Z","timestamp":1760330997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181119303925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0923181119303925"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.12.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"type":"print","value":"0923-1811"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD22 and CD72 contribute to the development of scleroderma in a murine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}